|Articles|March 8, 2022

Pharmaceutical Executive

  • Pharmaceutical Executive-03-01-2022
  • Volume 42
  • Issue 3

Pharmaceutical Executive, March 2022 Issue (PDF)

Click the title above for a link to open the Pharmaceutical Executive March 2022 issue in an interactive PDF format.

Articles in this issue

almost 4 years ago

Pressed Into Action: Measuring Pharma’s Reputation Reversal

almost 4 years ago

Biopharma in 2021: Big Gains, Volatile Values

almost 4 years ago

The Resilience of R&D: Pharma Posted Record Output in 2021

almost 4 years ago

A Complex Patent & Pricing Picture: Regulating Psychedelics More of a Journey Than a Trip

almost 4 years ago

New Age of Psychedelics

almost 4 years ago

Roads Less Traveled

almost 4 years ago

Biopharma Stocks, M&A Sputter Amid More Headwinds

almost 4 years ago

Pandemic Accelerates CTV Ascent: How Pharma Can Benefit

almost 4 years ago

The Human Factor in Data Security Breaches

almost 4 years ago

Tapping the Surge in Useful Contingent Labor Market

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!